Published in Curr Opin Otolaryngol Head Neck Surg on April 01, 2013
Knee lymphocutaneous fistula secondary to knee arthroplasty. Case Rep Orthop (2014) 0.75
Management of Chyle Leak after Head and Neck Surgery: Review of Current Treatment Strategies. Int J Otolaryngol (2017) 0.75
Thoracic Duct Chylous Fistula Following Severe Electric Injury Combined with Sulfuric Acid Burns: A Case Report. Am J Case Rep (2016) 0.75
High-volume bilateral chylothorax presenting with hypoxemia and shock in a pediatric patient following tracheostomy revision: a case report. J Med Case Rep (2015) 0.75
Management of cervical thoracic duct cyst with cyst-venous anastomosis. Int J Surg Case Rep (2014) 0.75
A review of the postoperative lymphatic leakage. Oncotarget (2017) 0.75
Superselective retrograde lymphatic duct embolization for management of postoperative lymphatic leak. Diagn Interv Radiol (2017) 0.75
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol (2009) 6.51
Diagnosis and management of primary chylous ascites. J Vasc Surg (2006) 1.72
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis. Lancet Oncol (2006) 1.44
HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study. Oncology (2005) 1.41
Shoulder disability after different selective neck dissections (levels II-IV versus levels II-V): a comparative study. Laryngoscope (2005) 1.37
Current views on diagnostic approach and treatment of lymphedema. Am J Med (2012) 1.21
Head and neck intramuscular haemangioma: report of two cases with unusual localization. Eur Arch Otorhinolaryngol (2003) 1.19
Congenital pulmonary lymphangiectasia. Orphanet J Rare Dis (2006) 1.18
Transoral CO(2) laser treatment for T(is)-T(3) glottic cancer: the University of Brescia experience on 595 patients. Head Neck (2010) 1.15
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. J Immunol (2011) 1.11
Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial. J Natl Cancer Inst (2011) 1.05
Microsurgery for lymphedema: clinical research and long-term results. Microsurgery (2010) 1.05
Vocal outcome after endoscopic cordectomies for Tis and T1 glottic carcinomas. Ann Otol Rhinol Laryngol (2003) 1.00
Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Genet A (2009) 1.00
Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death. BMC Cancer (2012) 0.98
Pemetrexed for the treatment of non-small cell lung cancer. Expert Opin Pharmacother (2013) 0.96
Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine. Curr Drug Targets (2015) 0.95
Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer. Arch Otolaryngol Head Neck Surg (2007) 0.94
The spinal accessory nerve in head and neck surgery. Curr Opin Otolaryngol Head Neck Surg (2007) 0.94
Differential expression of nuclear lamins in normal and cancerous prostate tissues. Oncol Rep (2006) 0.93
Hennekam syndrome presenting as nonimmune hydrops fetalis, congenital chylothorax, and congenital pulmonary lymphangiectasia. Am J Med Genet A (2003) 0.92
The lymphatics in the pathophysiology of thoracic and abdominal surgical pathology: immunological consequences and the unexpected role of microsurgery. Microsurgery (2007) 0.92
The medical oncologist's role in palliative care: AIOM's position. Tumori (2010) 0.91
The application of atmospheric pressure matrix-assisted laser desorption/ionization to the analysis of long-term cryopreserved serum peptidome. Anal Biochem (2011) 0.90
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition. Target Oncol (2014) 0.90
Diagnostic accuracy of magnetic resonance imaging in the assessment of mandibular involvement in oral-oropharyngeal squamous cell carcinoma: a prospective study. Arch Otolaryngol Head Neck Surg (2004) 0.90
Prevalence and localization of nodal metastases in squamous cell carcinoma of the oral cavity: role and extension of neck dissection. Eur Arch Otorhinolaryngol (2006) 0.88
Lymphatic microsurgery to treat lymphedema: techniques and indications for better results. Ann Plast Surg (2013) 0.88
Complement C3f serum levels may predict breast cancer risk in women with gross cystic disease of the breast. J Proteomics (2013) 0.88
Analysis of recurrences in 322 Tis, T1, or T2 glottic carcinomas treated by carbon dioxide laser. Ann Otol Rhinol Laryngol (2004) 0.88
Comparison of functional outcomes after endoscopic versus open-neck supraglottic laryngectomies. Ann Otol Rhinol Laryngol (2006) 0.87
Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol (2009) 0.87
Microsurgery for treatment of peripheral lymphedema: long-term outcome and future perspectives. Microsurgery (2007) 0.87
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer. Cancer Immunol Immunother (2013) 0.86
Supracricoid partial laryngectomies after radiation failure: a multi-institutional series. Head Neck (2008) 0.85
Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis. Cell Oncol (2008) 0.85
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer. Future Oncol (2013) 0.85
Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg (2004) 0.84
Transoral CO2 laser microsurgery for Tis-T3 supraglottic squamous cell carcinomas. Eur Arch Otorhinolaryngol (2010) 0.84
Diagnostic assessment and therapeutic approach for immunodeficiency due to chylous dysplasia: A case report. Microsurgery (2010) 0.84
Cervical spondylodiscitis: a rare complication after phonatory prosthesis insertion. Head Neck (2006) 0.83
Carbon dioxide laser salvage surgery after radiotherapy failure in T1 and T2 glottic carcinoma. Otolaryngol Head Neck Surg (2004) 0.83
Deep inferior epigastric artery perforated rectus abdominis free flap for head and neck reconstruction. Eur Arch Otorhinolaryngol (2011) 0.83
Prognostic value of cell cycle regulatory proteins in muscle-infiltrating bladder cancer. J Cancer Res Clin Oncol (2006) 0.83
European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer. Eur Arch Otorhinolaryngol (2014) 0.83
Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications. Anticancer Res (2005) 0.82
Surgical prevention of arm lymphedema after breast cancer treatment. Ann Surg Oncol (2011) 0.82
Idiopathic subglottic stenosis: management by endoscopic and open-neck surgery in a series of 30 patients. Eur Arch Otorhinolaryngol (2002) 0.82
Single skull metastasis 15 years after primary treatment of prostate cancer and with undetectable PSA levels: a case report and review of the literature. Tumori (2013) 0.81
Prognostic value of nuclear matrix protein expression in localized prostate cancer. J Cancer Res Clin Oncol (2012) 0.81
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer. Breast Cancer Res Treat (2010) 0.81
Primary bladder angiosarcoma with no apparent previous exposure to carcinogens: a case report. Anal Quant Cytopathol Histpathol (2013) 0.81
Lymphatic complications in surgery: possibility of prevention and therapeutic options. Updates Surg (2012) 0.81
Phonosurgery after endoscopic cordectomies. I. Primary intracordal autologous fat injection after transmuscular resection: preliminary results. Eur Arch Otorhinolaryngol (2007) 0.81
Endoscopic treatment of cT2 glottic carcinoma: prognostic impact of different pT subcategories. Ann Otol Rhinol Laryngol (2005) 0.80
Neurinoma originating from the recurrent nerve: report of a case. Surg Today (2008) 0.80
Afatinib for the treatment of advanced non-small-cell lung cancer. Expert Opin Pharmacother (2014) 0.80
Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines. Anticancer Res (2005) 0.80
Function preservation using transoral laser surgery for T2-T3 glottic cancer: oncologic, vocal, and swallowing outcomes. Eur Arch Otorhinolaryngol (2013) 0.80
Oral vinorelbine in the treatment of non-small-cell lung cancer. Expert Opin Pharmacother (2014) 0.80
Endoscopic treatment for early glottic cancer: indications and oncologic outcome. Otolaryngol Clin North Am (2006) 0.79
Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. Breast Cancer Res Treat (2011) 0.79
Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines. Prostate (2011) 0.79
Renal cell carcinoma metastatic to the larynx. Otolaryngol Head Neck Surg (2004) 0.79
Pre- and intraoperative assessment of mid-cord erythroleukoplakias: a prospective study on 52 patients. Eur Arch Otorhinolaryngol (2003) 0.79
Endothelial cells increase the radiosensitivity of oropharyngeal squamous carcinoma cells in collagen gel. Oral Oncol (2004) 0.78
Role of immunotherapy in the treatment of advanced non-small-cell lung cancer. Future Oncol (2014) 0.78
Recent advances in surgical management of parapharyngeal space tumors. Curr Opin Otolaryngol Head Neck Surg (2015) 0.78
Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema. Ann Surg Oncol (2008) 0.78
Microsurgery for groin lymphocele and lymphedema after oncologic surgery. Microsurgery (2013) 0.78
Prostatic and urothelial metastasis in the same lymph node: a case report. Anal Quant Cytopathol Histpathol (2015) 0.78
Use of metronomic chemotherapy in oncology: results from a national Italian survey. Tumori (2011) 0.77
Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP prostate cancer cell lines. Anticancer Res (2013) 0.77
Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy. Expert Opin Biol Ther (2014) 0.77
Lymphoscintigraphic evaluation of congenital lymphedema of the newborn. Clin Nucl Med (2002) 0.77
Preoperative and postoperative voice in Tis-T1 glottic cancer treated by endoscopic cordectomy: an additional issue for patient counseling. Ann Otol Rhinol Laryngol (2003) 0.77
Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia. Clin Exp Metastasis (2012) 0.77
Immunohistochemistry in non-immune hydrops fetalis: a single center experience in 79 fetuses. Am J Med Genet A (2010) 0.77
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era. Int J Hematol (2010) 0.77
Great auricular nerve preservation in parotid gland surgery: Long-term outcomes. Laryngoscope (2014) 0.77
Safety of antiandrogen therapy for treating prostate cancer. Expert Opin Drug Saf (2014) 0.77
Nonimmune idiopathic hydrops fetalis and congenital lymphatic dysplasia. Am J Med Genet A (2006) 0.77
Effects of bicalutamide and 4OH-tamoxifen on androgen-regulated gene expression in the LNCaP cell line. Anticancer Res (2012) 0.76
Pediatric lymphedema and correlated syndromes: role of microsurgery. Microsurgery (2008) 0.76
Internal jugular vein patency after lateral neck dissection: a prospective study. Eur Arch Otorhinolaryngol (2002) 0.76
Clinical and pathological response to primary chemotherapy in patients with locally advanced breast cancer grouped according to hormonal receptors, Her2 status, grading and Ki-67 proliferation index. Anticancer Res (2009) 0.76
Belagenpumatucel-L for the treatment of non-small cell lung cancer. Expert Opin Biol Ther (2015) 0.76
Functional and pharmacodynamic evaluation of metronomic cyclophosphamide and docetaxel regimen in castration-resistant prostate cancer. Future Oncol (2013) 0.76
Reasonable limits for transoral laser microsurgery in laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg (2016) 0.76
Free drugs in clinical trials and their potential cost saving impact on the National Health Service: a retrospective cost analysis in Italy. Lung Cancer (2013) 0.76
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma. J Thorac Oncol (2015) 0.75
Reconstructive microsurgery for lymphedema: while the early bird catches the worm, the late riser still benefits. J Am Coll Surg (2013) 0.75